AIMC Topic: Drug Discovery

Clear Filters Showing 881 to 890 of 1689 articles

From computer-aided drug discovery to computer-driven drug discovery.

Drug discovery today. Technologies
Computational chemistry and structure-based design have traditionally been viewed as a subset of tools that could aid acceleration of the drug discovery process, but were not commonly regarded as a driving force in small molecule drug discovery. In t...

How can artificial intelligence be used for peptidomics?

Expert review of proteomics
INTRODUCTION: Peptidomics is an emerging field of omics sciences using advanced isolation, analysis, and computational techniques that enable qualitative and quantitative analyses of various peptides in biological samples. Peptides can act as useful ...

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening.

Journal of chemical information and modeling
Virtual screening is receiving renewed attention in drug discovery, but progress is hampered by challenges on two fronts: handling the ever-increasing sizes of libraries of drug-like compounds and separating true positives from false positives. Here,...

A Convolutional Neural Network System to Discriminate Drug-Target Interactions.

IEEE/ACM transactions on computational biology and bioinformatics
Biological targets are most commonly proteins such as enzymes, ion channels, and receptors. They are anything within a living organism to bind with some other entities (like an endogenous ligand or a drug), resulting in change in their behaviors or f...

MCN-CPI: Multiscale Convolutional Network for Compound-Protein Interaction Prediction.

Biomolecules
In the process of drug discovery, identifying the interaction between the protein and the novel compound plays an important role. With the development of technology, deep learning methods have shown excellent performance in various situations. Howeve...

Facing small and biased data dilemma in drug discovery with enhanced federated learning approaches.

Science China. Life sciences
Artificial intelligence (AI) models usually require large amounts of high-quality training data, which is in striking contrast to the situation of small and biased data faced by current drug discovery pipelines. The concept of federated learning has ...

Artificial intelligence-driven phenotyping of zebrafish psychoactive drug responses.

Progress in neuro-psychopharmacology & biological psychiatry
Zebrafish (Danio rerio) are rapidly emerging in biomedicine as promising tools for disease modelling and drug discovery. The use of zebrafish for neuroscience research is also growing rapidly, necessitating novel reliable and unbiased methods of neur...

Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target interactions.

Molecular diversity
Identifying drug-target protein association pairs is a prerequisite and a crucial task in drug discovery and development. Numerous computational models, based on different assumptions and algorithms, have been proposed as an alternative to the labori...

The Trifecta of Single-Cell, Systems-Biology, and Machine-Learning Approaches.

Genes
Together, single-cell technologies and systems biology have been used to investigate previously unanswerable questions in biomedicine with unparalleled detail. Despite these advances, gaps in analytical capacity remain. Machine learning, which has re...

Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Molecular diversity
Neurological disorders affect various aspects of life. Finding drugs for the central nervous system is a very challenging and complex task due to the involvement of the blood-brain barrier, P-glycoprotein, and the drug's high attrition rates. The ava...